Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Array Technologies, Inc.
Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
IPO Date: October 15, 2020
Sector: Technology
Industry: Solar
Market Cap: $1.13B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.53 | 3.24%
Avg Daily Range (30 D): $0.24 | 3.41%
Avg Daily Range (90 D): $0.22 | 3.67%
Institutional Daily Volume
Avg Daily Volume: 4.28M
Avg Daily Volume (30 D): 7.85M
Avg Daily Volume (90 D): 6.15M
Trade Size
Avg Trade Size (Sh.): 121
Avg Trade Size (Sh.) (30 D): 179
Avg Trade Size (Sh.) (90 D): 161
Institutional Trades
Total Inst.Trades: 5,650
Avg Inst. Trade: $2.26M
Avg Inst. Trade (30 D): $1.98M
Avg Inst. Trade (90 D): $2.08M
Avg Inst. Trade Volume: .15M
Avg Inst. Trades (Per Day): 4
Market Closing Trades
Avg Closing Trade: $5.06M
Avg Closing Trade (30 D): $5.3M
Avg Closing Trade (90 D): $3.79M
Avg Closing Volume: 349.37K
   
News
Jun 25, 2025 @ 1:50 AM
Array Technologies Announces Pricing of Upsized Of...
Source: Array Technologies, Inc.
Jun 18, 2025 @ 12:16 PM
Array Technologies Boosts Solar Play With $179 Mil...
Source: Nabaparna Bhattacharya
Jun 18, 2025 @ 10:30 AM
ARRAY Technologies to Acquire APA Solar
Source: Globe Newswire
Jun 6, 2025 @ 4:03 PM
Record $3.3 Trillion Global Energy Investment: Whi...
Source: Surbhi Jain
May 6, 2025 @ 11:00 AM
ARRAY Technologies, Inc. Reports Financial Results...
Source: Array Technologies, Inc.
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $.02 $-1.02
Diluted EPS $.02 $-1.02
Revenue $ $ 302.36M $ 231.41M
Gross Profit $ $ 76.43M $ 78.32M
Net Income / Loss $ $ 16.75M $ -141.35M
Operating Income / Loss $ $ 27.28M $ -132.68M
Cost of Revenue $ $ 225.94M $ 153.09M
Net Cash Flow $ $ -14.65M $ 50.05M
PE Ratio